×

Weissman: Mylan must exert self-control

2:05 PM ET Wed, 24 Aug 2016

Paul Howard, Manhattan Institute Senior Fellow director of the Center for Medical Progress, and Robert Weissman, Public Citizen president, share their take on Mylan, the EpiPen pricing outrage and regulation versus the free market.